本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IN8bio, Inc.

1.28
+0.07005.79%
盤前1.22-0.0600-4.69%04:00 EDT
成交量:10.59萬
成交額:13.19萬
市值:1,260.43萬
市盈率:-0.68
高:1.30
開:1.23
低:1.18
收:1.21
52周最高:2.73
52周最低:0.8800
股本:984.71萬
流通股本:719.06萬
量比:2.26
換手率:1.47%
股息:- -
股息率:- -
每股收益(TTM):-1.8935
每股收益(LYR):-4.4441
淨資產收益率:-111.11%
總資產收益率:-58.37%
市淨率:0.69
市盈率(LYR):-0.29

資料載入中...

2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

SEC問詢函

Form CORRESP - Correspondence
2026/05/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/13

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/09

重要事件披露

Form 8-K - Current report
2026/01/26

SEC問詢函

Form CORRESP - Correspondence
2025/12/19

重要事件披露

Form 8-K - Current report